Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 06 04:00PM ET
153.51
Dollar change
-1.18
Percentage change
-0.76
%
IndexDJIA, S&P 500 P/E26.48 EPS (ttm)5.80 Insider Own0.13% Shs Outstand2.41B Perf Week0.42%
Market Cap369.59B Forward P/E13.89 EPS next Y11.05 Insider Trans-0.15% Shs Float2.40B Perf Month6.86%
Income14.07B PEG5.37 EPS next Q2.65 Inst Own72.62% Short Float0.72% Perf Quarter-2.99%
Sales88.82B P/S4.16 EPS this Y6.08% Inst Trans0.66% Short Ratio1.97 Perf Half Y-3.43%
Book/sh29.14 P/B5.27 EPS next Y4.38% ROA8.58% Short Interest17.20M Perf Year-1.47%
Cash/sh8.43 P/C18.21 EPS next 5Y4.93% ROE20.89% 52W Range140.68 - 168.85 Perf YTD6.15%
Dividend Est.5.10 (3.32%) P/FCF17.82 EPS past 5Y0.55% ROI13.87% 52W High-9.08% Beta0.48
Dividend TTM4.91 (3.20%) Quick Ratio0.79 Sales past 5Y2.03% Gross Margin76.27% 52W Low9.12% ATR (14)2.48
Dividend Ex-DateFeb 18, 2025 Current Ratio1.03 EPS Y/Y TTM15.10% Oper. Margin23.66% RSI (14)60.75 Volatility1.18% 1.77%
Employees131900 Debt/Eq0.51 Sales Y/Y TTM-4.51% Profit Margin15.84% Recom2.17 Target Price168.94
Option/ShortYes / Yes LT Debt/Eq0.45 EPS Q/Q-15.14% Payout84.80% Rel Volume0.82 Prev Close154.69
Sales Surprise0.40% EPS Surprise2.43% Sales Q/Q5.28% EarningsJan 22 BMO Avg Volume8.74M Price153.51
SMA203.26% SMA503.52% SMA200-0.25% Trades Volume7,123,108 Change-0.76%
Date Action Analyst Rating Change Price Target Change
Dec-10-24Resumed BofA Securities Neutral $166
Nov-15-24Initiated Wolfe Research Outperform $190
Jul-23-24Downgrade Daiwa Securities Outperform → Neutral $160 → $150
May-30-24Resumed Goldman Neutral $160
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Feb-06-25 05:07AM
01:08AM
Feb-05-25 09:59AM
09:06AM
Feb-04-25 06:01AM
04:30PM Loading…
Feb-03-25 04:30PM
08:02AM
04:30AM
03:50AM
Feb-02-25 02:23PM
12:21PM
Feb-01-25 08:34AM
07:30AM
06:14AM
03:34AM
05:12PM Loading…
Jan-31-25 05:12PM
02:23PM
Jan-30-25 12:18PM
Jan-29-25 10:29PM
02:04PM
09:27AM
05:00AM
Jan-28-25 01:11PM
11:45AM
09:40AM
07:35AM
06:12AM
06:01AM
12:19AM
Jan-27-25 01:52PM
09:00AM Loading…
09:00AM
Jan-25-25 11:05AM
10:50AM
06:17AM
Jan-24-25 07:14AM
04:51AM
02:01AM
Jan-23-25 04:57PM
03:40PM
02:01PM
12:42PM
12:30PM
11:45AM
08:08AM
08:00AM
07:31AM
05:35AM
05:08AM
02:02AM
01:01AM
Jan-22-25 08:28PM
04:41PM
04:33PM
04:32PM
03:52PM
02:16PM
02:00PM
01:44PM
12:54PM
12:48PM
12:03PM
11:32AM
11:15AM
10:22AM
09:36AM
09:30AM
09:09AM
08:25AM
08:21AM
07:34AM
07:30AM
06:29AM
06:23AM
06:20AM
Jan-21-25 09:46PM
07:00PM
11:57AM
11:42AM
08:00AM
06:01AM
06:00AM
05:34AM
04:17AM
Jan-20-25 02:30PM
09:54AM
Jan-19-25 01:00PM
12:33PM
07:41AM
05:00AM
Jan-18-25 07:02PM
05:01PM
12:31PM
10:10AM
06:18AM
Jan-17-25 10:24AM
07:38AM
Jan-16-25 05:45PM
09:15AM
09:11AM
02:10AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEINBERGER MARK ADirectorDec 12 '24Buy147.221,000147,2201,000Dec 12 05:27 PM
Hait WilliamFormer OfficerDec 04 '24Proposed Sale149.9025,7423,858,598Dec 04 01:25 PM
Decker Robert JVP Corporate ControllerAug 30 '24Option Exercise100.065,635563,83824,608Sep 03 04:48 PM
Decker Robert JVP Corporate ControllerAug 30 '24Sale165.065,635930,11318,973Sep 03 04:48 PM
Decker Robert JOfficerAug 30 '24Proposed Sale165.065,635930,113Aug 30 03:51 PM
Broadhurst VanessaEVP, Global Corp AffairsJul 08 '24Option Exercise0.009,809024,852Jul 09 05:48 PM
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '24Option Exercise0.0022,255022,561May 03 04:31 PM
Broadhurst VanessaEVP, Global Corp AffairsMar 13 '24Sale162.168,8911,441,76515,043Mar 13 04:36 PM
JOHNSON & JOHNSON10% OwnerFeb 29 '24Option Exercise0.723,8552,7924,103,430Mar 06 03:42 PM
JOHNSON & JOHNSON10% OwnerFeb 16 '24Sale25.813,72596,1424,099,575Mar 06 03:42 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '24Option Exercise0.00651082,599Feb 15 04:53 PM
Wolk Joseph JExec VP, CFOFeb 13 '24Option Exercise0.001,780069,663Feb 15 04:53 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '24Option Exercise0.001,3020155,517Feb 15 04:53 PM
Swanson James D.EVP, CIOFeb 13 '24Option Exercise0.00447014,765Feb 15 04:53 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '24Option Exercise0.00499013,290Feb 15 04:53 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13 '24Option Exercise0.009250112,550Feb 15 04:53 PM
Hait WilliamSee RemarksFeb 13 '24Option Exercise0.00834039,074Feb 15 04:53 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '24Option Exercise0.003,4700364,809Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '24Option Exercise0.00408024,143Feb 15 04:53 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '24Option Exercise0.0065108,576Feb 15 04:53 PM
Decker Robert JVP Corporate ControllerFeb 13 '24Option Exercise0.00313019,059Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 12 '24Option Exercise0.004,701025,081Feb 14 06:36 PM
Hait WilliamSee RemarksFeb 12 '24Option Exercise0.008,932042,316Feb 14 06:36 PM
Wolk Joseph JExec VP, CFOFeb 12 '24Option Exercise0.0025,835078,699Feb 14 06:36 PM
Forminard ElizabethExecutive VP, General CounselFeb 12 '24Option Exercise0.002,85908,959Feb 14 06:36 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 12 '24Option Exercise0.0026,2020167,618Feb 14 06:36 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12 '24Option Exercise0.0014,9600118,644Feb 14 06:36 PM
Swanson James D.EVP, CIOFeb 12 '24Option Exercise0.005,456016,013Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 12 '24Option Exercise0.0036,6180377,239Feb 14 06:36 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 12 '24Option Exercise0.005,736015,678Feb 14 06:36 PM
Decker Robert JVP Corporate ControllerFeb 12 '24Option Exercise0.001,912019,269Feb 14 06:36 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 12 '24Option Exercise0.0013,813089,014Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 09 '24Option Exercise90.44130,96911,844,836439,283Feb 13 05:18 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Option Exercise90.4459,3975,371,865200,813Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08 '24Option Exercise0.003,7390143,329Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Sale156.2759,3979,281,969141,416Feb 12 07:25 PM
Duato JoaquinCEO and Chairman of the BoardFeb 08 '24Option Exercise0.005,2250310,583Feb 12 07:25 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 08 '24Option Exercise0.001,971067,905Feb 12 07:25 PM
Wolk Joseph JExec VP, CFOFeb 08 '24Option Exercise0.003,686053,911Feb 12 07:25 PM
Forminard ElizabethExecutive VP, General CounselFeb 08 '24Option Exercise0.0097906,463Feb 12 07:24 PM
Swanson James D.See RemarksFeb 08 '24Option Exercise0.001,868011,111Feb 12 07:24 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 08 '24Option Exercise0.001,964010,943Feb 12 07:24 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08 '24Option Exercise0.002,1350104,465Feb 12 07:24 PM
Hait WilliamSee RemarksFeb 08 '24Option Exercise0.003,059034,497Feb 12 07:24 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 08 '24Option Exercise0.001,880021,083Feb 12 07:24 PM
Decker Robert JVP Corporate ControllerFeb 08 '24Option Exercise0.00655017,572Feb 12 07:24 PM